FDA Commissioner Scott Gottlieb was tapped by President Donald Trump to reform an agency the president had criticized as ‘slow and burdensome.’ | Micaela Rodriguez/POLITICOShare on Facebook Share on Twitter
Helping foster gene therapies; overhauling medical device reviews; using nutrition to fight disease: They’re all priorities for FDA in 2018, Commissioner Scott Gottlieb said on POLITICO’s “Pulse Check” podcast.
“We’re going to announce in the next couple of weeks a policy road map,” Gottlieb said. “[It’s] going to lay out what our 2018 agenda’s going to be, or at least a good part of it.”
Gottlieb, who was tapped by President Donald Trump to reform an agency the president had criticized as “slow and burdensome,” has overseen a flurry of activity to speed up FDA, including approving more than 1,000 generic drugs last year,